- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 195.88M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $272.02M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $275.58M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $15M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $15M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $75.78M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $67.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $359.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $610.66M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $319.71M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $116.98M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $679.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $479.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $59.15M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $21.55M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 175.52M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $195K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $20.45M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $26.61M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5.74M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.41M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $19.26M |
| Revenue | Q1 2025 · Mar 31, 2024 | $75.35M |